{"id":"NCT01372150","sponsor":"Pfizer","briefTitle":"A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD","officialTitle":"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11-17","primaryCompletion":"2015-03-20","completion":"2015-03-20","firstPosted":"2011-06-13","resultsPosted":"2015-11-20","lastUpdate":"2019-01-15"},"enrollment":340,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"desvenlafaxine succinate sustained release","otherNames":[]},{"type":"DRUG","name":"fluoxetine","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"DVS SR","type":"EXPERIMENTAL"},{"label":"Fluoxetine","type":"OTHER"},{"label":"Placebo","type":"EXPERIMENTAL"}],"summary":"This is a Double-blind Study Evaluating Desvenlafaxine Succinate (DVS SR) Sustained Release vs Placebo in the Treatment of Children and Adolescent Outpatients with Major Depressive Disorder (MDD).","primaryOutcome":{"measure":"Change From Baseline to Week 8 in the Children's Depression Rating Scale, Revised (CDRS-R) Total Score","timeFrame":"Baseline and Week 8","effectByArm":[{"arm":"Placebo","deltaMin":-23.07,"sd":1.18},{"arm":"Fluoxetine","deltaMin":-24.79,"sd":1.17},{"arm":"DVS SR","deltaMin":-22.61,"sd":1.17}],"pValues":[{"comp":"OG000 vs OG001","p":"0.226"},{"comp":"OG000 vs OG002","p":"0.739"}]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":43,"countries":["United States","Mexico"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B2061014&StudyName=A%20Study%20Of%20DVS%20SR%20In%20Treatment%20Of%20Children%20And%20Adolescent%20Outpatients%20With%20MDD"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":112},"commonTop":["Headache","Abdominal pain upper","Nausea","Nasopharyngitis","Vomiting"]}}